We have developed a model system for progression ofhuman epithelial cells to malignancy, using a human papillomavirus type 18 (HPV-18)-immortalized human keratinocyte cell line. Cells of cell line FEP-1811 were nontumorigenic in athymic mice through at least 12 passages in culture, but after 32 passages were weakly tumorigenic, producing tumors that regressed. After 62 passages they produced invasive squamous cell carcinomas that grew progressively. The progression to malignancy was associated with an increase in the efficiency of forming colonies in soft agar and with altered differentiation properties. In an organotypic culture system, FEP-1811 cells at passages 12 and 32 exhibited features typical of premalignant intraepithelial neoplasia in vivo, and cells at passage 68 exhibited features consistent with squamous cell carcinomas. No change in copy number of the transfected HPV-18 genome or in the level of expression of the viral transforming gene products E6 and E7 was detected between tumorigenic and nontumorigenic cells. Cytogenetic analysis of cells at early, middle, and late passage levels and cells cultured from tumors revealed that several chromosomal abnormalities segregated with the tumorigenic cell populations.
ABSTRACT
We have developed a model system for progression ofhuman epithelial cells to malignancy, using a human papillomavirus type 18 (HPV-18)-immortalized human keratinocyte cell line. Cells of cell line FEP-1811 were nontumorigenic in athymic mice through at least 12 passages in culture, but after 32 passages were weakly tumorigenic, producing tumors that regressed. After 62 passages they produced invasive squamous cell carcinomas that grew progressively. The progression to malignancy was associated with an increase in the efficiency of forming colonies in soft agar and with altered differentiation properties. In an organotypic culture system, FEP-1811 cells at passages 12 and 32 exhibited features typical of premalignant intraepithelial neoplasia in vivo, and cells at passage 68 exhibited features consistent with squamous cell carcinomas. No change in copy number of the transfected HPV-18 genome or in the level of expression of the viral transforming gene products E6 and E7 was detected between tumorigenic and nontumorigenic cells. Cytogenetic analysis of cells at early, middle, and late passage levels and cells cultured from tumors revealed that several chromosomal abnormalities segregated with the tumorigenic cell populations.
Human papillomaviruses (HPVs) infect epithelial cells at a variety ofanatomical sites. Infection by most ofthe -60 HPV types identified is associated with benign lesions. However, a subset of HPVs, including HPV types 16, 18, 31, , are frequently detected in tumors of the anogenital track and are suspected etiological agents for such tumors (1) . Evidence showing that these same HPV types are also present in histologically normal cells (2) and evidence from epidemiological studies (1) suggest that events additional to HPV infection are necessary for progression to malignant disease.
Human epithelial cells, the in vivo target of HPV infections, can be cultured readily in vitro, but no cell culture system has been developed that permits HPV replication. Therefore, models for a role that HPVs may have in the etiology of malignancies that contain them have relied primarily on the results of transfection studies. From such studies, it is clear that the HPVs frequently detected in anogenital carcinomas, such as HPV-16 and -18, exhibit transforming functions in a variety of rodent cell types. HPV types associated more with benign epithelial lesions, such as HPV-6 and -11, have a reduced or no transformation potential (3) . Transfection studies of subgenomic fragments of HPV-16 and -18 have identified the E6 and E7 genes as the principal transforming genes (3) (4) (5) (6) (7) (8) . In corroboration of these results are studies showing that the E6 and E7 proteins interact with the cellular p53 (9) and retinoblastoma (10) tumor-suppressor gene products, respectively. The transformed phenotypes induced in rodent cells by expression of transfected HPVs or their transforming genes have varied but include cell immortalization (4, 6) as well as transformation to tumorigenicity (11) . In contrast, when transfected into human epithelial cells, the transforming potential of HPV-16 or HPV-18 sequences appears limited to causing cell immortalization (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) and associated alterations in differentiation (19) (20) (21) . There have been no reports of tumorigenic transformation of human epithelial cells after their transfection with HPV sequences alone, and the only mechanism described for the conversion of HPV-immortalized human epithelial cells in culture to tumorigenicity has been by transfection of an HRAS oncogene (22, 23 
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Organotypic Culture. Organotypic "raft" cultures were prepared and processed as described by Kopan et al. (25) with the exception that human foreskin fibroblasts were used in the collagen matrix instead of mouse 3T3 J2 cells. Cultures were fed daily and harvested after 10 days of growth at the air/liquid interface. For harvesting, cultures were formaldehyde-fixed, paraffin-embedded, sectioned, and hematoxylin/ eosin-stained. Organotypic culture experiments were repeated at least twice.
Assay for Anchorage Independence. Exponentially growing cells were diluted to 1000 cells per ml in KGM containing 0.33% SeaPlaque agar (FMC), and 2 ml were plated on 60-mm dishes containing 4 ml of 2% solidified bottom agar in KGM. Cells were fed twice weekly with KGM. After 2 weeks, colonies with a diameter of >60 Aum were counted microscopically.
Tumorigenicity. Exponentially growing cells (5 x 106) were injected subcutaneously into 4-to 6-week-old BALB/c athymic mice that had been irradiated with 300 rad from a 'Co source 24 hr previously.
DNA and RNA Analysis. Genomic DNA was analyzed for the presence of HPV-18 sequences by the method of Southern (26) . RNA blot-hybridization (Northern) analysis was carried out as described (26) .
Radioimnunoprecipitation of the E6 and E7 Gene Products. Cellular proteins were labeled with 500 ,uCi (1 ,Ci = 37 kBq) of [35S]methionine (Translabel, ICN) and 500,Ci of [35S]cysteine (Amersham) in KGM containing no methionine or cysteine. Cell lysates were immunoprecipitated by using rabbit polyclonal sera raised against bacterial fusion proteins containing the HPV-18 E6-encoded polypeptide (a gift from Denise A. Galloway and Steve Jenison) or E7-encoded polypeptide as previously described (27) . Proteins were separated on SDS/17.5% polyacrylamide gels and detected by fluorography.
Cytogenetic Analysis. Chromosome preparations were performed in situ (28) . Chromosome modal number and chromosomal aberrations were determined from at least 40 G-banded metaphases.
RESULTS
The FEP-1811 cell line used in this study acquired an indefinite life-span in culture (i.e., were immortalized) after transfection with a vector plasmid containing the entire HPV-18 genome interrupted in the El open reading frame (16) . The cell line was propagated continuously in culture after immortalization, and populations were frozen for storage at various passage levels. Cell strains were established from FEP-1811 cells originally frozen at passage levels 12, 32, and 59 (cells were passaged at a split ratio of 1:4; thus each passage represents approximately two population doublings). These strains were designated S1, S2, and S3, respectively. Each of these strains was characterized as described below within 10 passages from the passage level at which they were originally frozen.
Morphology and Growth Properties. The S1, S2, and S3 FEP-1811 cell populations exhibited morphological features distinct from one another. A morphologically heterogeneous population of cells was observed with S1 cells (Fig. 1C) (Fig. 1B) with features comparable to those of normal squamous epithelium. In contrast, FEP-1811 S1 cells exhibited abnormal differentiation properties with parabasal layer crowding and some small nucleated cells extending up to the cornified layer (Fig. 1D) . The differentiation profile of S1 cells is similar to that observed with mild-to-moderate dysplasia in vivo. S1 cells were tested for the ability to form tumors in athymic mice by injecting 5 x 106 cells s.c. No tumors or evidence of any in vivo growth were apparent with these cells over a period of >9 mo (Table 1) . S2 cells exhibited a similar stratification profile compared to S1 cells but with more crowding at the parabasal layer and more nucleated cells extending up to and within the cornified layer (Fig. 1F ). S2 cells exhibited features similar to those observed in moderate to severe displasia in vivo. When tested for tumor-forming ability, S2 cells formed tumors in three of five mice injected ( Table 1 ). The tumors formed required =6 wk to reach a diameter of 0.4 cm. Two of the three tumors regressed, leaving only residual necrotic tumor tissue by 8 weeks, and the other tumor was removed for histological examination. The biopsied tumor was diagnosed as a poorly differentiated squamous cell carcinoma. Cells were also cultured from this tumor (designated S2Ti), and their tumorigenic properties were retested. S2T1 cells produced tumors in each of five mice injected (Table 1) . These tumors required only 3 weeks to reach a diameter of 0.4 cm, but like tumors produced by S2 cells, these tumors also regressed.
S3 cells completely lacked the ability to differentiate to form a cornified layer on qollagen rafts (Fig. 1H) Expression of the E6 and E7 gene products in S1, S2, and S3 cells was determined by radioimmunoprecipitation analysis. Cells from each of these cell strains expressed comparable amounts of the HPV-18 E7 protein (Fig. 3A) . HPV-18 E7 expression in HeLa cells was used as a positive control. Expression of HPV-18 E6 protein was more difficult to determine in S1, S2, and S3 cells, as well as in HeLa cells. However, a protein migrating at 16-17 kDa, the expected size for the HPV-18 E6 protein (29) , was present in FEP-1811 cells but not in normal human keratinocytes (Fig. 3B) .
Karyotype Analysis of FEP-1811 Cells. We previously showed that the FEP-1811 cell populations at passage 36(S2) and 59 (S3) contained a number of chromosome aberrations (30) . We have extended that study here to include S1 cells and FEP-1811 cells derived from tumors formed by S2 and S3 cells. A representative karyotype of cells derived from a tumor produced by S3 cells is shown in Fig. 4 . A consistent feature of FEP-1811 cells at different passage levels has been the maintenance of a nearly diploid karyotype that included aberrations in chromosomes 3 [der(3)], 6 [der(6)], 7 [der(7)], 13 [der (13) analyzed, the tumorigenic populations (S2 and S3) contained three additional changes. These included loss of a chromosome 21 and the Y chromosome, and an aberration in chromosome 5 (5q+). These changes appeared to segregate specifically with tumorigenic populations. This is because none of the chromosomal abnormalities found in the tumorigenic populations (-21, -Y, and 5q+) were observed in 50 metaphases prepared from S1 cells, but 50%6 of metaphases prepared from S2 cells and 100o of metaphases prepared from cells cultured from a tumor produced by S2 cells (S2T1) contained these three specific changes. Furthermore, 100o of metaphases prepared from S3 cells showed loss of chro- (30) suggest that such transformation to tumorigenicity might have been the result of chromosomal instability induced through the action of the principal transforming proteins of these viruses, E6 and E7. If such a mechanism were operating, it would be expected that one would see karyotypic abnormalities arise continuously as these cell lines were passaged in culture. For each of the cell lines generated in this laboratory, including the FEP-1811 cell line, the abnormal karyotype present at early passage levels persisted with few changes after extensive passaging (30) . Furthermore, if the E6 and E7 proteins were involved in causing FEP-1811 cells to become tumorigenic, then transformation to tumorigenicity would be expected in the other HPV-immortalized cell lines. None of these other cell lines generated in this laboratory (14, 16, 17) and no HPV-immortalized human epithelial cell lines generated in other laboratories (12, 13, 15, (18) (19) (20) (21) have proved to be tumorigenic. Therefore, our results are more consistent with a model in which the progression to tumorigenicity observed with the FEP-1811 cell line resulted from alterations in the cellular genome that occurred in a spontaneous manner independent of E6 and E7 expression.
Other than HPVs, the only other agent capable of immortalizing human epithelial cells in culture is simian virus 40 (SV40) (31) . Similar to studies with HPV-immortalized human epithelial cells (22, 23) , SV40-immortalized cells have been transformed into tumorigenic cells following the introduction of a RAS oncogene (32) . In a study by Brown identified. This aberration appeared to involve an interstitial deletion in the q arm of chromosome 5 and addition of an undetermined chromosome fragment(s). This aberration, along with loss of chromosome 21 and the Y chromosome, segregated with tumorigenic populations. It is not known whether these chromosome changes played a role in the conversion of FEP-1811 cells to malignancy. Of interest, however, is the proximity of the 5q aberration observed in tumorigenic FEP-1811 cells to the adenomatous polyposis coli locus (34) .
The demonstrated potency of RAS oncogenes in converting HPV-and SV40-immortalized human epithelial cells to malignancy (22, 23, 32) suggested that one of these genes may have been activated at some stage of the progression of FEP-1811 cells to malignancy. However, our initial studies examining RAS genes for activating mutations have revealed that no codon 12 mutations in HRAS, KRAS, or NRAS exist in any of the FEP-1811 cell populations (data not shown). We have not yet tested for the presence of other activating RAS mutations. We also have found no changes in the level of expression of the cellular MYC protein in the FEP-1811 cell populations (data not shown). Increased levels of MYC protein have been observed in some cervical carcinoma samples (35) .
The progression to tumorigenicity of FEP-1811 cells provides a model system from which the genetic, cytogenetic, and phenotypic alterations that potentially mark the progression to malignancy of human epithelial cells in vivo may be dissected. However, it is likely that the events responsible for progression to tumorigenicity and the sequence of occurrence of these events in our in vitro model system represent only one of many routes to tumorigenicity. Therefore, it is important to develop additional model systems to analyze and compare phenotypes that arise and to determine how such phenotypes may relate to in vivo cellular alterations associated with increased risk of epithelial malignancies.
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